ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullishCelltrion Inc
17 Dec 2022 03:19

Celltrion Group Companies - Sharp Increase in Dividends

Celltrion Inc, Celltrion Healthcare, and Celltrion Pharm all announced much higher dividend payments for this year as compared to last year.

Logo
551 Views
Share
bullishEcopro BM
21 Aug 2022 15:37

Overheated Short Selling Designation in Korea: Precise Definitions for the Confusing Terms

This post aims to explain Korea's overheated short-selling designation rules and provide precise definitions for the confusing terms.

Logo
340 Views
Share
bearishCelltrion Inc
04 Jun 2022 15:29

FnGuide Top 10 Rebalancing: How We Trade Shinhan IN/Celltrion OUT

This post looks at the FnGuide Top 10 Index (TIGER ETF) rebalancing results as we are past the screening period and suggests a trading approach on...

Logo
516 Views
Share
27 Mar 2022 07:49

ECM Weekly (27th Mar 2022) - JD, Tencent, Prosus, Ferretti, Recbio, Nomura, Navi, Samsung, Celltrion

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
382 Views
Share
bullishCelltrion Inc
21 Mar 2022 23:02

Block Deal Sale of Celltrion & Celltrion Healthcare by ION Investment

It was announced that ION Investment will partially sell its stakes in Celltrion and Celltrion Healthcare for about 560 billion won in a block...

Logo
380 Views
Share
x